Pathway-instructed therapeutic selection of ruxolitinib reduces neuroinflammation in fungal postinfectious inflammatory syndrome.

Sci Adv · 2025 · PMC11927619 · PMID 40117367

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

near-significantno p-value reported

IL-8 showed near-significant reduction and no major changes in the T helper 2 cytokine IL-13 ( Fig. 5Q ).

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.